There are a number of arms to this trial, each taking approx 12-16 weeks with varying doses in each arm (hence the 9 month estimated completion date).
The Fast Track designation they've received will basically open up the door for more frequent meetings / communication with the FDA.
Another box ticked today. GLTA
- Forums
- ASX - By Stock
- SNT
- News: PXS Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis
News: PXS Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis, page-9
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.29M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.2¢ | $8.803K | 275.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1747120 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 324051 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1247120 | 0.031 |
3 | 1146000 | 0.030 |
7 | 1770012 | 0.029 |
6 | 2415714 | 0.028 |
3 | 2270057 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 482851 | 4 |
0.033 | 885850 | 4 |
0.034 | 1000000 | 1 |
0.035 | 36518 | 2 |
0.036 | 243902 | 1 |
Last trade - 14.48pm 15/08/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online